MedPath

ALIPZA 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

ALIPZA 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Pending
Register Number

5324629

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jul 29, 2019

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number5324629
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

PITAVASTATINAActive
Quantity: 2 mg
Name: PITAVASTATINA

ATC CLASSIFICATION (3)

C10A
C10AA
C10AA08

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.